Immunovant will not pursue further development of IMVT-1402 for skin lupus after a trial missed its main goal, despite some ...

Too many with lupus are stuck in the gap between being too sick to work, but not sick enough for disability, says columnist ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Even though I know the characters with lupus are fictional, I’m filled with empathy and a little ...

The U.S. Food and Drug Administration (FDA) has agreed to allow Kyverna Therapeutics to begin clinical testing of KYV-101, the company’s investigational cell therapy for lupus nephritis, a form of ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The National Institute of Diabetes and Digestive and Kidney ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab) as an add-on treatment for adults with lupus nephritis, a form of lupus marked by kidney damage. Lupus is an autoimmune ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Seattle Children’s has been cleared by the U.S. Food and Drug ...

Brepocitinib, an investigational oral therapy, failed to show any benefits beyond a placebo in a Phase 2 clinical trial that tested it in adults with moderate to severely active systemic lupus ...

Severe flare-ups of systemic lupus erythematosus (SLE) among patients were associated with a markedly higher risk of stroke, according to the results of a population-based study in Taiwan that ...

Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google A 27-year-old woman with hard-to-treat systemic lupus ...

Patient screening is underway in a U.S.-based clinical trial of NKX019, an investigational natural killer (NK) cell therapy for people with treatment-resistant lupus nephritis, a serious complication ...